Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.

Type 2 diabetes patients taking semaglutide, often sold as Ozempic or Wegovy, have a slightly lower risk of stroke compared ...

EXCLUSIVE: The dialysis company believes the impact of the treatments on its own performance will be ‘neutral to positive’ ...

Glucagon-Like-Peptide-1 Agonists, like Ozempic, have become extremely popular for weight loss. Here are some of the side ...

They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...